The Arg353Gln polymorphism reduces the level of coagulation factor VII: In vivo and in vitro studies

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2825-2829

  Hunault, Mathilde ^a   Arbini, Arnaldo A ^a   Lopaciuk, Stanislaw ^b   Carew, Josephine A ^a   Bauer, Kenneth A ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^c VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Factor VII; Factor VII gene; Polymorphism; Triglycerides

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; COMPLEMENTARY DNA; TRIACYLGLYCEROL;

AMINO ACID ANALYSIS; AMINO ACID SUBSTITUTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; DNA DETERMINATION; GENETIC POLYMORPHISM; HUMAN; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CELL CULTURE; CELL STRAIN COS1; CHO CELL; CODON; COMPARATIVE STUDY; CRICETULUS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GENOTYPE; HAMSTER; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLAND;

ANIMALS; CELLS, CULTURED; CHO CELLS; CODON; COS CELLS; CRICETINAE; CRICETULUS; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; FACTOR VII; FACTOR VII DEFICIENCY; FACTOR VIIA; GENOTYPE; HUMANS; MUTAGENESIS, INSERTIONAL; POINT MUTATION; POLAND; POLYMORPHISM, GENETIC; TRANSFECTION; TRIGLYCERIDES;

EID: 0031283266     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2825     Document Type: Article

References (16)

1. Hagen FS, Gray CL, O'Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA. 1986;83:2412-2416.
2. Fair DS. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by radioimmunoassay. Blood. 1983;62:784-791.
3. Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A. 1977;74:5260-5264.
4. Bauer KA, Kass BL, ten Cate H, Hawiger JJ, Rosenberg RD. Factor IX is activated in vivo by the tissue factor mechanism. Blood. 1990;76:731-736.
5. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533-537.
6. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 1993;342:1076-1079.
7. Heinrich J, Balleisen L, Schulte H, Assman G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb. 1994;14:54-59.
8. Miller G, Stirling Y, Esnouf M, Heinrich J, van de Loo J, Kienast J, Wu K, Morrissey J, Meade T, Martin J, Imeson J, Cooper J, Finch A. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemostas. 1994;71:38-48.
9. Meade TW. The Epidemiology of Haemostatic and Other Variables in Coronary Artery Disease. Leuven, Belgium: Leuven University Press; 1987:37-60.
10. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy inidviduals. Arterioscler Thromb. 1991;11:540-546.
11. Humphries SE, Lane A, Dawson S, Green FR. The study of gene-environment interactions that influence thrombosis and fibrinolysis: genetic variation at the loci for factor VII and plasminogen activator inhibitor-1. Arch Pathol Lab Med. 1992;116:1322-1329.
12. Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost. 1996;75:567-572.
13. Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jonew HW, Rary JM. Analysis of human Y chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA. 1977;74:1245-1249.
14. Arbini AA, Bodkin D, Lopaciuk S, Bauer KA. Molecular analysis of Polish patients with factor VII deficiency. Blood. 1994;84:2214-2220.
15. Arbini AA, Pollak ES, Bayleran JK, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter. Blood. 1997;89:176-182.
16. Kaufman RJ, Davies MV, Wasley LC, Michnick D. Improved vectors for stable expression of foreign genes in mammalian cells by use of the untranslated leader sequence from EMC virus. Nucleic Acids Res. 1991;19:4485-4490.